Contact us

Contact us

Singular CRO. Extensive Expertise.

Exponential Success.

About PX’


 

Do you want to speed up the development of your biologics?  Are you interested in ensuring the industrial potential of your drug candidate?  Do you aim at facilitating entry to clinical trials for your promising biologics?

 

PX’Therapeutics, a new brand of Promise Proteomics, offers customized recombinant protein production for scientists performing drug development or basic research who require mg/g scale of proteins for preliminary studies.

 

Further capabilities include production of stable isotope labelled proteins and antibodies for use as internal standards in quantitative LC-MS through Promise Proteomics brand (visit Promise website).

 

The benefits of PX’Therapeutics’ services is to provide flexibility and reactivity for a one-time service or a continuous program enabling the scientists to move protein projects more rapidly and adopt series of different protein studies.

 

PX’ brings you the experience gained in one thousand successful projects.

Our clients think that we are “creative and problem solving oriented, professional, flexible and responsive” and 100% of them would recommend us.

 

Discover PX’Therapeutics

 

 

                     

Key facts


 

2000

 

Date of creation of the company

250

 

Clients : big groups, biotechs, academics

>1000

 

Finalised projects

>95%

 

Satisfied customers

Testimonies


 

“PX’Therapeutics Team has always been devoted to our project and had made every efforts to bring solutions for improving manufacturing process and product quality.”

Sylvain Fleury – CSO, Mymetics (Switzerland)

“Reducing cost of good was key for Intervacc. We entrusted PX’Therapeutics for process optimization before commercial production on our vaccine candidate. They achieved a great productivity gain in optimized timelines. We appreciated their problem-solving spirit, flexibility and reactivity.”

Jan-Ingmar Flock – CEO, Intervacc AB (Sweden)

Contact us